Discontinuation report OPTIMARK

Last updated on 2018-03-28
Report ID 8842
Drug Identification Number 02242986
Brand name OPTIMARK
Common or Proper name GADOVERSETAMIDE INJECTION
Company Name LIEBEL-FLARSHEIM CANADA INC
Active Ingredient(s) GADOVERSETAMIDE
Strength(s) 330.9MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 5, 10, 15, 20mL vials
ATC code V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for discontinuation Business reasons
Anticipated discontinuation date 2017-12-31
Actual discontinuation date 2018-03-23
Remaining supply date 2018-03-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 7500 TRANS-CANADA HIGHWAY
POINTE-CLAIRE, QUEBEC
CANADA H9R 5H8
Company contact information